MAR 06, 2020 9:07 PM PST

Drug Improves Cancer Therapy

WRITTEN BY: Nouran Amin

Prochlorperazine (PCZ) is a drug used for psychiatric use and the therapeutic treatment of nausea but was recently found to block the internalization of molecular receptors on the surface of tumor cells allowing more effective anticancer antibodies to avoid immune evasion.

"This represents a potentially disruptive change in clinical approaches to improve therapeutic targeting as the opportunity of temporarily moving drug targets within patient tumor cells becomes possible," says senior author Fiona Simpson, a cancer researcher at the University of Queensland.

PCZ was used as the temporary treatment of cancer in some patients and results yielded receptor clustering inside cancer cells of patients. Findings were published in the journal Cell.

"These findings highlight the crucial role of availability and persistence of the molecule targeted by the therapeutic antibody at the cell surface of tumor cells," Simpson says.

PCZ is also used in laboratory studies to inhibit a cellular process known as endocytosis—a mechanism that brings outside substances to the inside of the cell. Such inhibition has held clinical relevance for the control of viral infection.

Learn more about endocytosis:

To apply the mechanisms of PCZ, researchers analyzed tumor samples from patients and found a decrease in endocytosis of a protein known as epidermal growth factor receptor (EGFR). The particular protein was found to be inhibited by a cancer therapeutic called cetuximab.

"We found that if we stopped the drug targets getting inside the cells by inhibiting the uptake process, called endocytosis, we got a really big immune response against the tumors in mice," Simpson says. "This led to the concept that temporarily halting endocytosis of receptors that are the targets of monoclonal antibody therapies may be used to improve clinical outcomes.”

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 20, 2020
Cancer
Fighting Cancer with Black Pepper
JUL 20, 2020
Fighting Cancer with Black Pepper
In the never-ending search for the next treatment or cure, many researchers turn towards nature. The study of black pepp ...
AUG 11, 2020
Drug Discovery & Development
FDA Approves New Opioid for Short-Term Use
AUG 11, 2020
FDA Approves New Opioid for Short-Term Use
The US Food and Drug Administration has announced the approval of Olinvyk (oliceridine), a new opioid that can help mana ...
AUG 29, 2020
Drug Discovery & Development
MDMA and LSD Combo to Enter Clinical Trials
AUG 29, 2020
MDMA and LSD Combo to Enter Clinical Trials
Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Sch ...
SEP 08, 2020
Cardiology
Fixing Stem Cell Therapy for Heart Repair
SEP 08, 2020
Fixing Stem Cell Therapy for Heart Repair
Repairing the damage done by a heart attack has been of keen interest for decades. Some researchers think protecting the ...
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
SEP 01, 2020
Drug Discovery & Development
First Novel Compounds to Inhibit Cancer-Linked Enzymes
SEP 01, 2020
First Novel Compounds to Inhibit Cancer-Linked Enzymes
Researchers from the University of Michigan Rogel Cancer Center have worked on creating a therapeutic-based compound tha ...
Loading Comments...